Perspectum specializes in advanced imaging technologies that enhance the diagnosis and monitoring of various health conditions, particularly those related to liver and metabolic diseases. Their flagship product, LiverMultiScan, utilizes multiparametric MRI to non-invasively assess liver health by measuring critical biomarkers such as liver fat, iron concentration, and fibro-inflammation. This technology has demonstrated a strong correlation with histological measures, allowing for accurate monitoring of disease progression and treatment response. Additionally, the MRCP+ tool offers enhanced visualization and quantitative assessment of the biliary tree and pancreatic duct, facilitating better evaluation of pancreatobiliary diseases.

The company also emphasizes a patient-first approach, aiming to tailor precision medicine to individual needs. Their digital pathology solutions streamline the reporting process, enabling rapid and accurate assessments of tissue samples through a fully digitized workflow. This integration of advanced imaging and digital pathology not only improves diagnostic accuracy but also enhances the overall patient experience by reducing unnecessary procedures and expediting results. By leveraging these innovative technologies, Perspectum is committed to transforming healthcare through improved diagnostics and personalized treatment strategies.

United Kingdom

Perspectum's imaging solutions are safe, fast, and can offer more comprehensive diagnostics. We help doctors understand complex data and help deliver precision care to more patients. 

We believe the voice of the patient matters and that each case is unique. Our goal is to enable health care providers to tailor precision medicine to the needs of the individual.

Perspectum

Company Details